Group One Trading, L.P. Regulus Therapeutics Inc. Transaction History

Group One Trading, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.13 - $2.88 $9,725 - $24,788	8,607 New	8,607 $24,000
Q1 2023 May 12, 2023	SELL	$0.79 - $1.61 $5,390 - $10,985	-6,823 Reduced 93.27%	492 $0
Q4 2022 Feb 09, 2023	SELL	$1.17 - $1.85 $94 - $149	-81 Reduced 1.1%	7,315 $10,000
Q2 2022 Aug 11, 2022	BUY	$1.6 - $3.4 $11,833 - $25,146	7,396 New	7,396 $15,000

56.5M

79.3K

20.3K

Ticker RGLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,634,400
Market Cap $22.5M
Description
Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.